Biased research, aggressive sales, harmful drugs
The Health Policy Exchange
MAY 20, 2013
Unfortunately, recent case studies have illustrated that FDA approval does not necessarily provide assurances of effectiveness and safety. Health Policy Fellowship Department of Family Medicine Georgetown University School of Medicine The size of average doses would more than triple. Kenny Lin, MD Director, Robert L.
130 
Let's personalize your content